Mergers and acquisitions – Page 7
-
Business
Danaher boosts diagnostics with Cepheid buyout
$4bn deal strengthens Danaher’s life sciences portfolio
-
Business
Fertiliser firms Agrium and PotashCorp to merge
Canadian combination will create one of the largest crop nutrient companies in the world.
-
Business
Bayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
Business
Pfizer to buy Astrazeneca’s antibiotics
Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
-
Business
Pfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
Business
EU examines Dow–DuPont union
European commission probes competition implications of the planned mega-merger
-
Business
US government sued over merger crackdown
Business groups challenge Obama’s steps to limit tax inversions
-
Business
Amgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
Business
Arkema boosts Bostik adhesives
New adhesives plant in Sweden and acquisition of Dutch firm Den Braven
-
Business
Celgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
Business
Henkel to buy detergent maker Sun Products
€3.2bn deal boosts Henkel’s position in North American laundry care market
-
Business
AstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
Business
Novartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
Business
Sanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
Business
Teva sells off products in preparation for Allergan merger
Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
-
Business
BASF boosts coatings with Chemetall buyout
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
-
Business
Westlake Chemical to buy rival Axiall
US chemical manufacturer Axiall acquired by Westlake Chemical for $3.8 billion, after its earlier bid was rejected
-
Business
Merck & Co to buy Afferent for neurology drugs
Deal worth up to $1.25bn includes drug candidate for chronic coughs
-
Business
J&J to buy Vogue for haircare range
$3.3bn deal expands Johnson & Johnson’s consumer products segment